SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors interpret a recent regulatory filing updating executive change-of-control agreements as strategic preparation for a potential acquisition. This upward momentum is being further fueled by intense community discussion regarding a looming clinical catalyst and significant short-covering pressure in a stock with high borrow fees.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors weigh volatile price action against broader speculation surrounding government quantum initiatives and heavy insider selling. While some community members are betting on long-term growth and potential strategic partnerships, others remain skeptical, focusing on technical scaling challenges and the persistent lack of commercial revenue.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is facing intense community scrutiny and bearish sentiment as the stock decouples from Bitcoin, leading to heated debates over the sustainability of its debt-fueled acquisition model and dividend obligations. Traders are actively monitoring the stock for a potential bottom while weighing risks of further dilution against claims that it represents a generational buying opportunity.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is attracting intense community interest as it pivots toward AI-integrated financial infrastructure and tokenized stock trading, though shareholders remain divided between long-term optimism and frustration over recent downward price volatility. Investors are closely monitoring upcoming events and regulatory updates, while the stock continues to experience heavy short-selling pressure amidst broader concerns about market liquidity and sector correlation.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility as investors weigh significant options expirations against ongoing concerns regarding market manipulation and institutional exposure. Community discourse remains deeply polarized, with many debating the sustainability of current price levels amid bearish sentiment and uncertainty surrounding institutional proxy strategies.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense volatility and scrutiny as the market weighs its aggressive capacity expansion for Indium Phosphide substrates against ongoing concerns regarding high insider selling and potential share dilution. While some investors remain optimistic about the firm's central role in the AI optical networking supply chain, others are questioning the sustainability of its rapid valuation growth.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. is trending as investors weigh significant government loan commitments and a transformational acquisition against recent price volatility and sector-wide weakness. The community remains deeply divided, with bulls pointing to the company's strategic role in securing the domestic uranium and rare earth supply chain, while detractors express frustration over recent price declines and concerns regarding dilution.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is facing intense volatility as traders debate the impact of ongoing share dilution and heavy insider selling against the long-term potential of the company's fiber optics and AI data center expansion. The community remains deeply polarized, with some investors aggressively buying the pullback as a structural opportunity while others warn of technical breakdown and potential valuation risks.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing significant volatility and a downward trend as part of a broader sector-wide repricing that has hit AI and software stocks, with investors actively debating whether the stock is finding a bottom near key psychological levels or remains overvalued. Community discussion is heavily focused on the stock's valuation risk, the impact of high-profile short-selling activity, and whether current technical weakness represents a long-term entry point for a resilient business or a deeper correction.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending as investors react to positive analyst coverage and a recent operational expansion involving its Pennsylvania manufacturing facility. The community is actively discussing the company's long-term potential within the AI-driven grid infrastructure sector, while weighing the impact of continued share dilution against the momentum from new purchase orders and strategic partnerships.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Telix Pharmaceuticals Limited (NASDAQ:TLX) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine research firms that are presently covering the stock...

Telix Pharmaceuticals Webinar Highlights Next-Gen PSMA Therapy, OPTIMAL-PSMA Enrollment Nears End

Telix Pharmaceuticals (NASDAQ:TLX) hosted an educational webinar outlining its next-generation prostate-specific membrane antigen (PSMA) radiopharmaceutical strategy, with management and a clinical...

Regeneron Boosts Cancer Pipeline Through Telix Collaboration

Regeneron teams up with Telix in a 50/50 radiopharma deal, betting on next-gen cancer therapies to expand its oncology pipeline and long-term growth.

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - What's Next?

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - Time to Sell...

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Should You Buy?

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's Why...

Wedbush Reaffirms Outperform Rating for Telix Pharmaceuticals (NASDAQ:TLX)

Wedbush reissued an "outperform" rating and set a $22.00 price target on shares of Telix Pharmaceuticals in a report on Monday...

Telix Pharmaceuticals (NASDAQ:TLX) Given "Buy" Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Telix Pharmaceuticals in a research report on Monday...

Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Telix Pharmaceuticals Ltd. (TLX, TLX.AX) announced Monday a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies...

Telix And Regeneron Partner To Advance Next-Generation Radiopharmaceutical Therapies

(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) and Regeneron Pharmaceuticals, Inc. (REGN) have announced a collaboration to jointly develop and commercialize next-generation...

Telix Pharmaceuticals (NASDAQ:TLX) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Telix Pharmaceuticals Ltd. - ADR

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

Equity

Neutral Sentiment

$UBER only

$INTC only

Both $UBER and $INTC

Neither

Nancy Pelosi recently disclosed trades in both Uber ($UBER) and Intel ($INTC) - are you following her into either? Cast your vote below.

Are you following Nancy Pelosi into her latest trades - Uber ($UBER) and Intel ($INTC)?

Feed

News

Sentiment

Earnings

Fundamentals

Info

TLXTelix Pharmaceuticals Limited American Depositary Shares

Fundamentals

Latest TLX News